Ranibizumab

Ranibizumab

(Peptides) 

Stock Status : In-Stock
CAT No. : CS-O-11211
CAS:347396-82-1
Mol. Weight:48350 g/mol
Mol. Formula: C292H431N77O88S2

Details


Pamabrom

Pamabrom

(API Standards) 

Stock Status : Enquire
CAT No. : CS-O-02095
CAS:606-04-02
Mol. Weight:348.2 g/mol
Mol. Formula: C11H18BrN5O3

Details


Blinatumomab

Blinatumomab

(Peptides) 

Stock Status : Enquire
CAT No. : CS-O-11206
CAS:853426-35-4
Mol. Weight:6516.27 g/mol

Details


Tanezumab

Tanezumab

(Peptides) 

Stock Status : Enquire
CAT No. : CS-O-11325
CAS:880266-57-9
Mol. Weight:145.4 g/mol

Details


Daclizumab

Daclizumab

(Peptides) 

Stock Status : Enquire
CAT No. : CS-O-16306
CAS:152923-56-3
Mol. Weight:6657.51 g/mol
Mol. Formula: C299H454N80O89S2

Details


Dulaglutide

Dulaglutide

(Peptides) 

Stock Status : Enquire
CAT No. : CS-O-11201
CAS:923950-08-7
Mol. Weight:5659.09 g/mol

Details


Ixekizumab

Ixekizumab

(Peptides) 

Stock Status : Enquire
CAT No. : CS-O-16309
CAS:1143503-69-8
Mol. Weight:6618.49 g/mol

Details


Obiltoxaximab

Obiltoxaximab

(Peptides) 

Stock Status : Enquire
CAT No. : CS-O-16310
CAS:1351337-07-9

Details


Germaben II

Germaben II

(Impurities) 

Stock Status : Enquire
CAT No. : CS-P-08044
CAS:84517-95-3
Mol. Weight:686.68 g/mol
Mol. Formula: C29H42O15N4

Details


Bococizumab

Bococizumab

(Peptides) 

Stock Status : Enquire
CAT No. : CS-O-11324
CAS:1407495-02-6
Mol. Weight:145.1 g/mol
Mol. Formula: C6414H9918N1722O2012S54

Details


Pamabrom Related Compound A(Secondary Standards traceble to USP)

Pamabrom Related Compound A(Secondary Standards traceble to USP)

(Secondary Standards (traceble to Primary Standards)) 

Stock Status : Enquire
CAT No. : CS-ER-01592
CAS:85-18-7
Mol. Weight:214.61 g/mol
Mol. Formula: C7H7ClN4O2

Details


Infliximab (Y0002110)

Infliximab (Y0002110)

(EP Standards) 

Stock Status : Enquire
CAT No. : CS-EG-01107
CAS:170277-31-3
Mol. Weight:144190.3 g/mol
Mol. Formula: C6428H9912N1694O1987

Details


Pamabrom Related Compound A  (F069E0)

Pamabrom Related Compound A (F069E0)

(USP Standards) 

Stock Status : Enquire
CAT No. : CS-EB-01600
CAS:85-18-7
Mol. Weight:214.61 g/mol
Mol. Formula: C7H7ClN4O2

Details


Infliximab

Infliximab

(Peptides) 

Stock Status : Enquire
CAT No. : CS-O-14467
CAS:170277-31-3
Mol. Weight:144190.3 g/mol
Mol. Formula: C6428H9912N1694O1987

Details


Alirocumab

Alirocumab

(Peptides) 

Stock Status : Enquire
CAT No. : CS-O-14042
CAS:1245916-14-6
Mol. Formula: C6472H9996N1736O2032S42

Details


Bezlotoxumab

Bezlotoxumab

(Peptides) 

Stock Status : Enquire
CAT No. : CS-O-16302
CAS:1246264-45-8
Mol. Weight:145600 g/mol
Mol. Formula: C6464H9974N1726O2014S46

Details


Vedolizumab

Vedolizumab

(Peptides) 

Stock Status : Enquire
CAT No. : CS-O-11207
CAS:943609-66-3
Mol. Weight:146836.67 g/mol
Mol. Formula: C6528H10072N1732O2042S42

Details


Aflibercept

Aflibercept

(API Standards) 

Stock Status : Enquire
CAT No. : CS-O-11214
CAS:862111-32-8
Mol. Weight:6856.9 g/mol

Details